Talk:Darbepoetin alfa

Untitled
Moleculer weight = 37 kDa —Preceding unsigned comment added by 125.16.17.1 (talk) 06:34, 10 November 2009 (UTC)

Citation for manufacture using Chinse hamster ovary (CHO) cells can be found here in section 11 of the Aranesp full prescribing information, http://pi.amgen.com/united_states/aranesp/ckd/aranesp_pi_hcp_english.pdf That section also confirms the molecular weight info above.

"11 DESCRIPTION Aranesp (darbepoetin alfa) is an erythropoiesis-stimulating protein that is produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. Aranesp is a 165-amino acid protein that differs from recombinant human erythropoietin in containing 5 N-linked oligosaccharide chains, whereas recombinant human erythropoietin contains 3 chains. The 2 additional N-glycosylation sites result from amino acid substitutions in the erythropoietin peptide backbone. The approximate molecular weight of darbepoetin alfa is 37,000 daltons." — Preceding unsigned comment added by 68.82.238.149 (talk) 20:30, 4 February 2013 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified 5 one external links on Darbepoetin alfa. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Corrected formatting/usage for http://www.fda.gov/cder/foi/appletter/2001/darbamg091701L.htm
 * Added archive https://web.archive.org/web/20061017113846/http://emea.europa.eu/humandocs/PDFs/EPAR/aranesp/129901en1.pdf to http://www.emea.europa.eu/humandocs/PDFs/EPAR/aranesp/129901en1.pdf
 * Corrected formatting/usage for http://www.fda.gov/cder/drug/advisory/RHE2007.htm
 * Corrected formatting/usage for http://www.fda.gov/cder/drug/InfoSheets/HCP/RHE2007HCP.htm
 * Added archive https://web.archive.org/web/20141103190540/http://www.asco.org/quality-guidelines/asco-ash-clinical-practice-guideline-update-use-epoetin-and-darbepoetin-adult to http://www.asco.org/quality-guidelines/asco-ash-clinical-practice-guideline-update-use-epoetin-and-darbepoetin-adult

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at ).

Cheers.— InternetArchiveBot  (Report bug) 19:30, 6 December 2016 (UTC)